Doliver Capital Advisors LP purchased a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,110 shares of the pharmacy operator’s stock, valued at approximately $244,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of WBA. Northwestern Mutual Wealth Management Co. boosted its position in Walgreens Boots Alliance by 25.6% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 11,215 shares of the pharmacy operator’s stock valued at $932,000 after buying an additional 2,288 shares during the period. Private Harbour Investment Management & Counsel LLC raised its stake in shares of Walgreens Boots Alliance by 8.5% during the first quarter. Private Harbour Investment Management & Counsel LLC now owns 23,142 shares of the pharmacy operator’s stock valued at $1,922,000 after acquiring an additional 1,820 shares during the last quarter. Cabot Wealth Management Inc. raised its stake in shares of Walgreens Boots Alliance by 16.8% during the first quarter. Cabot Wealth Management Inc. now owns 3,154 shares of the pharmacy operator’s stock valued at $262,000 after acquiring an additional 453 shares during the last quarter. Regis Management CO LLC raised its stake in shares of Walgreens Boots Alliance by 4.6% during the first quarter. Regis Management CO LLC now owns 4,576 shares of the pharmacy operator’s stock valued at $380,000 after acquiring an additional 200 shares during the last quarter. Finally, Baird Financial Group Inc. raised its stake in shares of Walgreens Boots Alliance by 7.3% during the first quarter. Baird Financial Group Inc. now owns 308,923 shares of the pharmacy operator’s stock valued at $25,656,000 after acquiring an additional 20,896 shares during the last quarter. Institutional investors and hedge funds own 63.35% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Doliver Capital Advisors LP Takes $244,000 Position in Walgreens Boots Alliance, Inc. (WBA)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another domain, it was illegally copied and republished in violation of international copyright and trademark laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/11/22/doliver-capital-advisors-lp-takes-244000-position-in-walgreens-boots-alliance-inc-wba.html.

Several equities analysts have recently commented on the stock. Jefferies Group LLC set a $93.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Sunday, October 29th. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, October 5th. Finally, Robert W. Baird reaffirmed an “outperform” rating and set a $80.00 price objective (down from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $87.63.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at $71.16 on Wednesday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. Walgreens Boots Alliance, Inc. has a 52-week low of $63.82 and a 52-week high of $88.00. The firm has a market cap of $71,455.88, a P/E ratio of 13.88, a price-to-earnings-growth ratio of 1.26 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. During the same period last year, the firm earned $1.07 earnings per share. The company’s quarterly revenue was up 5.3% on a year-over-year basis. sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.25%. Walgreens Boots Alliance’s payout ratio is presently 42.33%.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock buyback plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board of directors believes its shares are undervalued.

In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John Anthony Lederer acquired 20,000 shares of the firm’s stock in a transaction dated Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.